CompletedNot Applicable

Subcision Followed by Diluted Calcium Hydroxylapatite Injection Versus Subcision Followed by Painting CROSS TCA Technique for the Treatment of Atrophic Acne Scars

Egypt13 participantsStarted 2023-01-01

Plain-language summary

This study aimed to compare the safety and efficacy of subcision followed by diluted calcium hydroxyapatite injection versus subcision followed by the painting original chemical reconstruction of skin scars (CROSS) technique using trichloroacetic acid (TCA) for the treatment of atrophic acne scars.

Who can participate

Age range20 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age from 20 to 50 years. * Both sexes. * Patients with atrophic acne scars. Exclusion Criteria: * Patients with Fitzpatrick skin phototypes V and VI. * Receiving systemic isotretinoin medication at the time of the study. * Active bacterial, viral or fungal infections in the treatment area. * Hypertrophic scarring or keloidal tendency. * Photosensitivity or photodermatitis. * Unrealistic expectation, bleeding, coagulation disorders, and any other related skin disease. * Pregnant or lactating females. * Chronic debilitating diseases such as diabetes mellitus, cardiovascular diseases, renal failure, hepatic diseases, chronic respiratory diseases or any endocrine diseases. * History of immunosuppressive drug intake or chemotherapy within 6 months before treatment.

What they're measuring

Patient satisfaction

Timeframe: One week

Trial details

NCT IDNCT07028567

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-22

View on ClinicalTrials.gov More Subcision trials